Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rudolph Emile Tanzi, Ph.D.

Co-Author

This page shows the publications co-authored by Rudolph Tanzi and Deborah Blacker.
Connection Strength

2.658
  1. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet. 1998 Aug; 19(4):357-60.
    View in: PubMed
    Score: 0.193
  2. The genetics of Alzheimer disease: current status and future prospects. Arch Neurol. 1998 Mar; 55(3):294-6.
    View in: PubMed
    Score: 0.187
  3. ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology. 1997 Jan; 48(1):139-47.
    View in: PubMed
    Score: 0.173
  4. No association between CALHM1 and Alzheimer's disease risk. Cell. 2008 Dec 12; 135(6):993-4; author reply 994-6.
    View in: PubMed
    Score: 0.099
  5. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet. 2008 Nov; 83(5):623-32.
    View in: PubMed
    Score: 0.098
  6. Exploring candidate gene associations with neuropsychological performance. Am J Med Genet B Neuropsychiatr Genet. 2007 Dec 05; 144B(8):987-91.
    View in: PubMed
    Score: 0.092
  7. Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Arch Neurol. 2007 Jun; 64(6):862-71.
    View in: PubMed
    Score: 0.089
  8. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet. 2007 Jan; 39(1):17-23.
    View in: PubMed
    Score: 0.086
  9. Is alpha-T catenin (VR22) an Alzheimer's disease risk gene? J Med Genet. 2007 Jan; 44(1):e63.
    View in: PubMed
    Score: 0.086
  10. Single-nucleotide polymorphism rs498055 on chromosome 10q24 is not associated with Alzheimer disease in two independent family samples. Am J Hum Genet. 2006 Jul; 79(1):180-3; author reply 183-4.
    View in: PubMed
    Score: 0.084
  11. The LDLR locus in Alzheimer's disease: a family-based study and meta-analysis of case-control data. Neurobiol Aging. 2007 Jan; 28(1):18.e1-4.
    View in: PubMed
    Score: 0.081
  12. Further evidence for LBP-1c/CP2/LSF association in Alzheimer's disease families. J Med Genet. 2005 Nov; 42(11):857-62.
    View in: PubMed
    Score: 0.080
  13. ACAT1 is not associated with Alzheimer's disease in two independent family-based samples. Mol Psychiatry. 2005 Jun; 10(6):522-4.
    View in: PubMed
    Score: 0.077
  14. Family-based association between Alzheimer's disease and variants in UBQLN1. N Engl J Med. 2005 Mar 03; 352(9):884-94.
    View in: PubMed
    Score: 0.076
  15. No association between a previously reported OLR1 3' UTR polymorphism and Alzheimer's disease in a large family sample. J Med Genet. 2004 Apr; 41(4):286-8.
    View in: PubMed
    Score: 0.071
  16. PEN2 is not a genetic risk factor for Alzheimer's disease in a large family sample. Neurology. 2004 Jan 27; 62(2):304-6.
    View in: PubMed
    Score: 0.071
  17. Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin. Hum Mol Genet. 2003 Nov 01; 12(21):2765-76.
    View in: PubMed
    Score: 0.069
  18. No association between marker D10S1423 and Alzheimer's disease. Mol Psychiatry. 2003 Jun; 8(6):571-3.
    View in: PubMed
    Score: 0.067
  19. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet. 2003 Jan 01; 12(1):23-32.
    View in: PubMed
    Score: 0.066
  20. No evidence for genetic association or linkage of the cathepsin D (CTSD) exon 2 polymorphism and Alzheimer disease. Ann Neurol. 2001 Jan; 49(1):114-6.
    View in: PubMed
    Score: 0.057
  21. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science. 2000 Dec 22; 290(5500):2302-3.
    View in: PubMed
    Score: 0.057
  22. Evidence against association of the FE65 gene (APBB1) intron 13 polymorphism in Alzheimer's patients. Neurosci Lett. 2000 Dec 15; 296(1):17-20.
    View in: PubMed
    Score: 0.057
  23. Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologies. Exp Gerontol. 2000 Dec; 35(9-10):1353-61.
    View in: PubMed
    Score: 0.057
  24. Genomic structure, expression pattern, and chromosomal localization of the human calsenilin gene: no association between an exonic polymorphism and Alzheimer's disease. Neurosci Lett. 2000 Nov 24; 294(3):135-8.
    View in: PubMed
    Score: 0.057
  25. Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aß, tau, immunity and lipid processing. Nat Genet. 2019 Sep; 51(9):1423-1424.
    View in: PubMed
    Score: 0.052
  26. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aß, tau, immunity and lipid processing. Nat Genet. 2019 03; 51(3):414-430.
    View in: PubMed
    Score: 0.050
  27. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet. 2017 09; 49(9):1373-1384.
    View in: PubMed
    Score: 0.045
  28. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol. 2015 Feb; 72(2):209-16.
    View in: PubMed
    Score: 0.038
  29. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA Neurol. 2014 Nov; 71(11):1394-404.
    View in: PubMed
    Score: 0.037
  30. Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet. 2012 Dec; 44(12):1349-54.
    View in: PubMed
    Score: 0.032
  31. Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology. 2012 Jul 17; 79(3):221-8.
    View in: PubMed
    Score: 0.032
  32. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011 May; 43(5):436-41.
    View in: PubMed
    Score: 0.029
  33. Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease. Alzheimer Dis Assoc Disord. 2010 Jan-Mar; 24(1):28-36.
    View in: PubMed
    Score: 0.027
  34. GAB2 as an Alzheimer disease susceptibility gene: follow-up of genomewide association results. Arch Neurol. 2009 Feb; 66(2):250-4.
    View in: PubMed
    Score: 0.025
  35. Assessment of Alzheimer's disease case-control associations using family-based methods. Neurogenetics. 2009 Feb; 10(1):19-25.
    View in: PubMed
    Score: 0.024
  36. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol. 2008 Jan; 65(1):94-100.
    View in: PubMed
    Score: 0.023
  37. Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease. Hum Mol Genet. 2007 Nov 15; 16(22):2703-12.
    View in: PubMed
    Score: 0.023
  38. Follow-up mapping supports the evidence for linkage in the candidate region at 9q22 in the NIMH Alzheimer's disease Genetics Initiative cohort. Am J Med Genet B Neuropsychiatr Genet. 2007 Mar 05; 144B(2):220-7.
    View in: PubMed
    Score: 0.022
  39. Longitudinal change in cognitive performance among individuals with mild cognitive impairment. Neuropsychology. 2007 Mar; 21(2):158-69.
    View in: PubMed
    Score: 0.022
  40. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology. 2005 Aug 09; 65(3):404-11.
    View in: PubMed
    Score: 0.020
  41. Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative. Am J Med Genet. 2000 Dec 04; 96(6):823-30.
    View in: PubMed
    Score: 0.014
  42. Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Hum Mol Genet. 1998 Nov; 7(12):1953-6.
    View in: PubMed
    Score: 0.012
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.